018443297

ZOVYDD

---

March 30, 2021

Trademark Summary

The trademark application ZOVYDD was filed by CureVac AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 13, 2021, and it was registered by office on September 20, 2021 without any oppositions.

The application was filed in English (German was selected as the second language).

---

Goods And Services

• The mark was filed in class 1 with Chemicals and biomolecules, in particular biological macromolecules, for industrial or scientific purposes and Reagents for research purposes...
• The mark was filed in class 5 with following description of goods:
  
  1. Chemical preparations for medical use
  2. Peptides for medical use
  3. Pharmaceutical and veterinary preparations
  4. Pharmaceuticals and medicines based on biological macromolecules or peptides or biological macromolecules associated to peptides for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumour diseases, for the treatment of metabolic disorders and for the treatment of inherited genetic diseases or for protein or enzyme replacement therapy
  5. Gene therapeutic preparations
  6. Adjuvants for medical purposes
  7. Peptide carrier molecules for association with a biological macromolecule
  8. Peptidic carrier molecule for preparing a pharmaceutical composition
  9. Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition
  10. Health care preparations for medical use
  11. Vaccines
  12. Vaccines for the prophylaxis of viral diseases..
• The mark was filed in class 42 with Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules and pre-clinical and clinical testing of macromolecules...
• The mark was filed in class 44 with Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders..